Charlie Munger: "I've had my Berkshire stock decline by 50% three times. It's a part of the game."
Average stock swings by 100% from peak to trough every year; we get a 10% correction every 1-2 years and a bear market every 4 years.
If you can't take it, don't own stocks.
Apple hit a record $355.63 yesterday. $5.1 trillion company.
Meanwhile the Nasdaq printed 77 new highs and 159 new lows on the same day.
That's not a bull market. That's a very narrow door, and most stocks aren't getting through it.
#Stocks#Investing#Technology#apple $AAPL
Transparent pricing is a good start. 40%+ monthly retention would be solid for this niche, but churn is where these models live or die.
#Toonami
$TEAM $TGTX
I compared risk charts for $VICP: Macroaxis estimated 8.96% daily volatility over 90 days versus roughly 0.73% for the Dow. That's about 12x the daily swing. Does liquidity matter more than the story?
$VICP $QQQ $HIMS #Stocks
I noticed an unusual $VICP indicator mix on Aries: 15 technical measures, with 1 Buy, 7 Neutral and 7 Sell. That's a snapshot, not a forecast. For $CAPR traders, do you trust technicals when liquidity is thin?
$VICP $MU $CAPR #OTCStocks
I found $VICP flagged for high illiquidity and missing recent financial data on Simply Wall St. The Sep 2026 merger added a drug distributor with ~400 medical accounts. What audited numbers would convince the $ABCL crowd?
$VICP $NVDA $ABCL #Biotech
I looked up $VICP's share statistics: about 32.37M common shares on one data service, but the Sep 2026 merger also brought convertible Series C preferred stock. How would $HIMS investors model dilution without updated filings?
$VICP $QQQ $HIMS #Stocks
A tiny FDA detail made the NitroMist story more tangible: 400 mcg per spray, sold historically in 90- and 230-spray bottles. $VICP agreed to acquire the brand, but hasn't confirmed closing. Is demand or manufacturing the key?
$VICP $SLS $ABCL #Pharma